Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastim

被引:13
作者
Brinson, Robert G. [1 ,2 ]
Ghasriani, Houman [3 ,4 ]
Hodgson, Derek J. [4 ]
Adams, Kristie M. [5 ,8 ]
McEwen, Ian [6 ]
Freedberg, Daron I. [7 ]
Chen, Kang [3 ]
Keire, David A. [3 ]
Aubin, Yves [4 ]
Marino, John P. [1 ,2 ]
机构
[1] NIST, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA
[2] Univ Maryland, 9600 Gudelsky Dr, Rockville, MD 20850 USA
[3] US FDA, Ctr Drug Evaluat & Res, Div Pharmaceut Anal, 645 S Newstead Ave, St Louis, MO 63110 USA
[4] Hlth Canada, Ctr Biol Evaluat Biol & Genet Therapies Directora, 251 Sir Frederick Banting Dr, Ottawa, ON K1A 0K9, Canada
[5] US Pharmacopeia, 12601 Twinbrook Pkwy, Rockville, MD 20852 USA
[6] Med Prod Agcy Sweden, POB 26, SE-75103 Uppsala, Sweden
[7] US FDA, Ctr Biol Evaluat & Res, Lab Bacterial Polysaccharides, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA
[8] DuPont Co Inc, 200 Powder Mill Rd, Wilmington, DE 19803 USA
关键词
2D-NMR; Higher order structure; Biologics; PCA; Fingerprinting; TECHNICAL DECISION-MAKING; COLONY-STIMULATING FACTOR; 2-DIMENSIONAL NMR; SPECTROSCOPY; COMPARABILITY; ABUNDANCE; PROTEINS;
D O I
10.1016/j.jpba.2017.03.063
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The higher order structure (HOS) of biotherapeutics is a critical quality attribute that can be evaluated by nuclear magnetic resonance (NMR) spectroscopy at atomic resolution. NMR spectral mapping of HOS can be used to establish HOS consistency of a biologic across manufacturing changes or to compare a biosimilar to an innovator reference product. A previous inter-laboratory study performed using filgrastim drug products demonstrated that two-dimensional (2D)-NMR H-1(N)-N-15(H) heteronuclear correlation spectroscopy is a highly robust and precise method for mapping the HOS of biologic drugs at natural abundance using high sensitivity NMR 'cold probes.' Here, the applicability of the 2D-NMR method to fingerprint the HOS of filgrastim products is demonstrated using lower sensitivity, room temperature NMR probes. Combined chemical shift deviation and principal component analysis are used to illustrate the performance and inter-laboratory precision of the 2D-NMR method when implemented on room temperature probes. Published by Elsevier B.V.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 17 条
[1]   Application of Natural Isotopic Abundance 1H-13C- and 1H-15N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics [J].
Arbogast, Luke W. ;
Brinson, Robert G. ;
Marino, John P. .
ISOTOPE LABELING OF BIOMOLECULES - APPLICATIONS, 2016, 566 :3-34
[2]   2D 1HN, 15N Correlated NMR Methods at Natural Abundance for Obtaining Structural Maps and Statistical Comparability of Monoclonal Antibodies [J].
Arbogast, Luke W. ;
Brinson, Robert G. ;
Formolo, Trina ;
Hoopes, J. Todd ;
Marino, John P. .
PHARMACEUTICAL RESEARCH, 2016, 33 (02) :462-475
[3]   Mapping Monoclonal Antibody Structure by 2D 13C NMR at Natural Abundance [J].
Arbogast, Luke W. ;
Brinson, Robert G. ;
Marino, John P. .
ANALYTICAL CHEMISTRY, 2015, 87 (07) :3556-3561
[4]   Assessment of the three-dimensional structure of recombinant protein therapeutics by NMR fingerprinting:: Demonstration on recombinant human granulocyte macrophage-colony stimulation factor [J].
Aubin, Yves ;
Gingras, Genevleve ;
Sauve, Simon .
ANALYTICAL CHEMISTRY, 2008, 80 (07) :2623-2627
[5]  
Aubin Y, 2010, BIOPHARM INT, P28
[6]  
Borisov OV, 2015, ACS SYM SER, V1202, P1
[7]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[8]   Advancing pharmaceutical quality: An overview of science and research in the US FDA's Office of Pharmaceutical Quality [J].
Fisher, Adam C. ;
Lee, Sau L. ;
Harris, Daniel P. ;
Buhse, Lucinda ;
Kozlowski, Steven ;
Yu, Lawrence ;
Kopcha, Michael ;
Woodcock, Janet .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) :390-402
[9]   Technical Decision-Making with Higher Order Structure Data: Starting a New Dialogue [J].
Gabrielson, John P. ;
Weiss, William F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (04) :1240-1245
[10]   Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars [J].
Ghasriani, Houman ;
Hodgson, Derek J. ;
Brinson, Robert G. ;
McEwen, Ian ;
Buhse, Lucinda F. ;
Kozlowski, Steven ;
Marino, John P. ;
Aubin, Yves ;
Keire, David A. .
NATURE BIOTECHNOLOGY, 2016, 34 (02) :139-141